期刊文献+

Screening for hepatocellular carcinoma by Egyptian physicians

Screening for hepatocellular carcinoma by Egyptian physicians
下载PDF
导出
摘要 AIM: To assess the practice of Egyptian physicians in screening patients for hepatocellular carcinoma(HCC). METHODS: The study included 154 physicians from all over Egypt caring for patients at risk for HCC. The study was based on a questionnaire with 20 items. Each questionnaire consisted of two parts:(1) personal information regarding the physician(name, age, specialty and type of health care setting); and(2) professional experience in the care of patients at risk for HCC development(screening, knowledge about the cause and natural course of liver diseases and HCC risk). RESULTS: Sixty-eight percent of doctors with an MD degree, 48% of doctors with a master degree or a diploma and 40% of doctors with a Bachelor of Medicine, Bachelor of Surgery certificate considered the hepatitis C virus(HCV) genotype as risk factor for HCC development(P < 0.05). Ninety percent of physicians specialized in tropical medicine, internal medicine or gastroenterology and 67% of physicians in other specialties advise patients to undergo screening for HCV and hepatitis B virus infection as well as liver cirrhosis(P < 0.05). Eighty-six percent of doctors in University Hospitals and 69% of Ministry of Health(MOH) doctors consider HCV infection as the leading cause of HCC in Egypt(P < 0.05). Seventy-two percent of doctors with an MD degree, 55% of doctors with a master degree or a diploma, 56% of doctors with an MBBCH certificate, 74% of doctors in University Hospitals and 46% of MOH hospital doctors consider abdominal ultrasonography as the most important investigation in HCC screening(P < 0.05). Sixty-five percent of physicians in tropical medicine, internal medicine or gastroenterology and 37% of physicians in other specialties recommend as HCC screening interval of 3 mo(P < 0.05). Seventy-one percent of doctors with an MD degree, 50% of doctors with a master degree or diploma and 60% of doctors with an MBBCH certificate follow the same recommendation.CONCLUSION: In Egypt, physicians specialized in tropical medicine, internal medicine or gastroenterology with an MD degree and working in a University Hospital are best informed about HCC. AIM: To assess the practice of Egyptian physicians in screening patients for hepatocellular carcinoma(HCC). METHODS: The study included 154 physicians from all over Egypt caring for patients at risk for HCC. The study was based on a questionnaire with 20 items. Each questionnaire consisted of two parts:(1) personal information regarding the physician(name, age, specialty and type of health care setting); and(2) professional experience in the care of patients at risk for HCC development(screening, knowledge about the cause and natural course of liver diseases and HCC risk). RESULTS: Sixty-eight percent of doctors with an MD degree, 48% of doctors with a master degree or a diploma and 40% of doctors with a Bachelor of Medicine, Bachelor of Surgery certificate considered the hepatitis C virus(HCV) genotype as risk factor for HCC development(P < 0.05). Ninety percent of physicians specialized in tropical medicine, internal medicine or gastroenterology and 67% of physicians in other specialties advise patients to undergo screening for HCV and hepatitis B virus infection as well as liver cirrhosis(P < 0.05). Eighty-six percent of doctors in University Hospitals and 69% of Ministry of Health(MOH) doctors consider HCV infection as the leading cause of HCC in Egypt(P < 0.05). Seventy-two percent of doctors with an MD degree, 55% of doctors with a master degree or a diploma, 56% of doctors with an MBBCH certificate, 74% of doctors in University Hospitals and 46% of MOH hospital doctors consider abdominal ultrasonography as the most important investigation in HCC screening(P < 0.05). Sixty-five percent of physicians in tropical medicine, internal medicine or gastroenterology and 37% of physicians in other specialties recommend as HCC screening interval of 3 mo(P < 0.05). Seventy-one percent of doctors with an MD degree, 50% of doctors with a master degree or diploma and 60% of doctors with an MBBCH certificate follow the same recommendation.CONCLUSION: In Egypt, physicians specialized in tropical medicine, internal medicine or gastroenterology with an MD degree and working in a University Hospital are best informed about HCC.
出处 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2015年第9期161-171,共11页 世界胃肠肿瘤学杂志(英文版)(电子版)
关键词 HEPATOCELLULAR CARCINOMA EGYPTIAN PHYSICIANS Scree Hepatocellular carcinoma Egyptian physicians Scree
  • 相关文献

参考文献20

  • 1Ashwani K. Singal,Amanpal Singh,Sathya Jaganmohan,Praveen Guturu,Rajasekhara Mummadi,Yong–Fang Kuo,Gagan K. Sood.Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related Cirrhosis[J].Clinical Gastroenterology and Hepatology.2010(2)
  • 2Yuan-Hung Kuo,Sheng-Nan Lu,Chao-Long Chen,Yu-Fan Cheng,Chih-Yun Lin,Chao-Hung Hung,Chien-Hung Chen,Chi-Sin Changchien,Hsuan-Chih Hsu,Tsung-Hui Hu,Chuan-Mo Lee,Jing-Houng Wang.Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis[J]. European Journal of Cancer . 2009 (4)
  • 3Shama C. Buch,Venkateswarlu Kondragunta,Robert A. Branch,Brian I. Carr.Gender-based outcomes differences in unresectable hepatocellular carcinoma[J]. Hepatology International . 2008 (1)
  • 4O. F. M. Couto,I. Dvorchik,B. I. Carr.Causes of Death in Patients with Unresectable Hepatocellular Carcinoma[J]. Digestive Diseases and Sciences . 2007 (11)
  • 5KAZUYUKIOHATA,KEISUKEHAMASAKI,KANTORIYAMA,HIROKIISHIKAWA,KAZUHIKONAKAO,KATSUMIEGUCHI.High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection[J]. Journal of Gastroenterology and Hepatology . 2004 (6)
  • 6Erzsébet Szabó,Csilla Páska,Pál Kaposi Novák,Zsuzsa Schaff,András Kiss.Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis[J]. Pathology & Oncology Research . 2004 (1)
  • 7Bo-Heng Zhang,Bing-Hui Yang,Zhao-You Tang.Randomized controlled trial of screening for hepatocellular carcinoma[J]. Journal of Cancer Research and Clinical Oncology . 2004 (7)
  • 8Sammy Saab,David Ly,Jose Nieto,Fasiha Kanwal,David Lu,Steven Raman,Rafael Amado,Barbara Nuesse,Francisco Durazo,Steven Han,Douglas G. Farmer,Rafik M. Ghobrial,Hasan Yersiz,Pauline Chen,Kathy Schwegel,Leonard I. Goldstein,Myron Tong,Ronald W. Busuttil.Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model[J]. Liver Transplantation . 2003 (7)
  • 9Miguel R Arguedas,Victor K Chen,Mohamad A Eloubeidi,Michael B Fallon.Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis[J]. The American Journal of Gastroenterology . 2003 (3)
  • 10Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis[J]. Hepatology . 2003 (3)

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部